BULLFROG AI HOLDINGS, INC. Interest Expense
BULLFROG AI HOLDINGS, INC. (BFRG) reported Interest Expense of $3.27 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2024-05-10
- BULLFROG AI HOLDINGS, INC. interest expense for the quarter ending 2024-03-31 was $3.27K, a 94.57% decline year-over-year.
- BULLFROG AI HOLDINGS, INC. interest expense for the quarter ending 2023-12-31 was $2.21K, a 98.04% decline year-over-year.
- BULLFROG AI HOLDINGS, INC. interest expense for the quarter ending 2023-09-30 was $5.76K, a 95.36% decline year-over-year.
- BULLFROG AI HOLDINGS, INC. interest expense for the quarter ending 2023-06-30 was $10.84K, a 88.47% decline year-over-year.
- BULLFROG AI HOLDINGS, INC. interest expense for fiscal 2023 was $79.09K, a 77.22% decline from fiscal 2022.
- BULLFROG AI HOLDINGS, INC. interest expense for fiscal 2022 was $347.14K, a 759.38% increase from fiscal 2021.
- BULLFROG AI HOLDINGS, INC. interest expense for fiscal 2021 was $40.40K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $3.27K 10-Q · filed 2024-05-10 | $5.48K derived: sum of 2 quarters · filed 2024-05-10 | $11.24K derived: sum of 3 quarters · filed 2024-05-10 | $22.08K derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-12-31 | $2.21K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $7.97K derived: sum of 2 quarters · filed 2024-03-29 | $18.81K derived: sum of 3 quarters · filed 2024-03-29 | $79.09K 10-K · filed 2024-03-29 |
| 2023-09-30 | $5.76K 10-Q · filed 2023-11-14 | $16.60K derived: sum of 2 quarters · filed 2023-11-14 | $76.88K 10-Q · filed 2023-11-14 | $189.36K derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-06-30 | $10.84K 10-Q · filed 2023-08-14 | $71.12K 10-Q · filed 2023-08-14 | $183.60K derived: sum of 3 quarters · filed 2024-05-10 | $307.76K derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-03-31 | $60.28K 10-Q · filed 2024-05-10 | $172.76K derived: sum of 2 quarters · filed 2024-05-10 | $296.92K derived: sum of 3 quarters · filed 2024-05-10 | $390.94K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $112.48K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $236.64K derived: sum of 2 quarters · filed 2024-03-29 | $330.66K derived: sum of 3 quarters · filed 2024-03-29 | $347.14K 10-K · filed 2024-03-29 |
| 2022-09-30 | $124.16K 10-Q · filed 2023-11-14 | $218.18K derived: sum of 2 quarters · filed 2023-11-14 | $234.67K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $94.02K 10-Q · filed 2023-08-14 | $110.51K 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | $16.49K 10-Q · filed 2023-05-24 | |||
| 2021-12-31 | $40.40K 10-K · filed 2023-04-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B |